Seminars in Thrombosis and Hemostasis, Inhaltsverzeichnis

Semin Thromb Hemost 2023; 49(01): 089-091
DOI: 10.1055/s-0042-1744301

Letter to the Editor

Acquired Thrombotic Thrombocytopenic Purpura: A Rare Coincidence after COVID-19 mRNA Vaccine?

Allison C. Y. Tso

¹Department of Haematology, Tan Tock Seng Hospital, Singapore, Singapore

,

Kiat H. Ong

¹Department of Haematology, Tan Tock Seng Hospital, Singapore, Singapore

,

Christina L. L. Sum

¹Department of Haematology, Tan Tock Seng Hospital, Singapore, Singapore

,

Bingwen E. Fan

¹Department of Haematology, Tan Tock Seng Hospital, Singapore, Singapore

,

Grace Y. L. Chan

²Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore, Singapore

,

Dheepa Christopher

¹Department of Haematology, Tan Tock Seng Hospital, Singapore, Singapore

,

Hwee S. Howe

²Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore, Singapore

,

Yi W. Lai

²Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore, Singapore

,

Xin R. Lim

²Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore, Singapore

,

Bernard P. L. Leung

²Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore, Singapore

³Health and Social Sciences, Singapore Institute of Technology, Singapore, Singapore

› Institutsangaben

References
1 Waqar SHB, Khan AA, Memon S. Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine. Int J Hematol 2021; 114 (05) 626-629
2 Sissa C, Al-Khaffaf A, Frattini F. et al. Relapse of thrombotic thrombocytopenic purpura after COVID-19 vaccine. Transfus Apheresis Sci 2021; 60 (04) 103145
3 Al-Ahmad M, Al-Rasheed M, Shalaby NAB. Acquired thrombotic thrombocytopenic purpura with possible association with AstraZeneca-Oxford COVID-19 vaccine. EJ Haem 2021; 2 (03) 534-536
4 Maayan H, Kirgner I, Gutwein O. et al. Acquired thrombotic thrombocytopenic purpura: a rare disease associated with BNT162b2 vaccine. J Thromb Haemost 2021; 19 (09) 2314-2317
5 Yocum A, Simon EL. Thrombotic thrombocytopenic purpura after Ad26.COV2-S vaccination. Am J Emerg Med 2021; 49: 441.e3-441.e4
6 de Bruijn S, Maes MB, De Waele L, Vanhoorelbeke K, Gadisseur A. First report of a de novo iTTP episode associated with an mRNA-based anti-COVID-19 vaccination. J Thromb Haemost 2021; 19 (08) 2014-2018
7 Recombinant SARS-CoV-2 Spike S1 Subunit Biotin Protein, CF. Accessed February 9, 2022 at: https://www.rndsystems.com/products/recombinant-sars-cov-2-spike-s1-subunit-biotin-protein-cf_bt10569#product-citations
8 Ouyang W, Xie T, Fang H. et al. Variable induction of pro-inflammatory cytokines by commercial SARS CoV-2 spike protein reagents: potential impacts of LPS on in vitro modeling and pathogenic mechanisms in vivo. Int J Mol Sci 2021; 22 (14) 7540
9 Platton S, Bartlett A, MacCallum P. et al. Evaluation of laboratory assays for anti-platelet factor 4 antibodies after ChAdOx1 nCOV-19 vaccination. J Thromb Haemost 2021; 19 (08) 2007-2013